dacarbazine and 2',2'-difluoro-2'-deoxyuridine

dacarbazine has been researched along with 2',2'-difluoro-2'-deoxyuridine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buesa, JM; Díaz, A; Esteban, E; Fernández, A; Fra, J; López-Pousa, A; Losa, R; Sierra, M	1

Trials

1 trial(s) available for dacarbazine and 2',2'-difluoro-2'-deoxyuridine

Article	Year
Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation. Cancer, 2004, Nov-15, Volume: 101, Issue:10 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Floxuridine; Gemcitabine; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Middle Aged; Sarcoma; Treatment Outcome	2004

Article

Year

Phase I clinical trial of fixed-dose rate infusional gemcitabine and dacarbazine in the treatment of advanced soft tissue sarcoma, with assessment of gemcitabine triphosphate accumulation.

Cancer, 2004, Nov-15, Volume: 101, Issue:10

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Floxuridine; Gemcitabine; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Maximum Tolerated Dose; Middle Aged; Sarcoma; Treatment Outcome

2004